top of page
After six years of Research & Development, OnTracka has benchmarked a new standard in providing patient-centred clinical trials
Without credible data and clinical research to evidence the safety & efficacy of these complex medicines, there is a total of over one billion people that will continue to not have access to Cannabis & Psychedelic Medicines as a means of preventing, treating and managing disease, mental health challenges and substance misuse disorders.
Chad Walkaden, Founder
bottom of page